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The pentadecaketide fredericamycin has the longest
carbon chain backbone among polycyclic aromatic
polyketide antibiotics whose biosynthetic genes
have been sequenced. This backbone is synthesized
by the bimodular fdm polyketide synthase (PKS).
Here, we demonstrate that the bimodular fdm PKS
as well as its elongation module alone synthesize un-
decaketides and dodecaketides. Thus, unlike other
homologs, the fdm ketosynthase-chain length factor
(KS-CLF) heterodimer does not exclusively control
the backbone length of its natural product. Using
sequence- and structure-based approaches, 48 CLF
multiple mutants were engineered and analyzed.
Unexpectedly, the I134F mutant was unable to turn
over but could initiate and partially elongate the poly-
ketide chain. This unprecedented mutant suggests
that the KS-CLF heterodimer harbors an as yet un-
characterizedchain terminationmechanism.Together,
our findings reveal fundamental mechanistic differ-
ences between the fdm PKS and its well-studied
homologs.
INTRODUCTION
Polyketide synthases (PKSs) are a large family of multienzyme
assemblies that catalyze the biosynthesis of structurally diverse
and medicinally important natural products (O’Hagan, 1991;
Rawlings, 1999; Staunton and Weissman, 2001). In analogy
with the evolutionarily related fatty acid synthases, they are clas-
sified into type I and type II PKSs (Hopwood and Sherman, 1990;
Smith and Tsai, 2007). The latter subclass of PKSs, which
resemble bacterial and plant fatty acid synthases, plays a de-
fining role in the biosynthesis of many polycyclic aromatic antibi-
otics produced by the actinomycetes (Das and Khosla, 2009;Chemistry & Biology 18, 1021–Hertweck et al., 2007). They invariably harbor a minimal PKS
module comprised of a ketosynthase (KS), a chain length factor
(CLF), an acyl carrier protein (ACP), and a malonyl-CoA:ACP
transacylase (MAT, usually from the housekeeping fatty acid
synthase in the bacterium). Collectively, these proteins catalyze
the formation of a poly-b-ketoacyl-ACP chain of defined length.
In addition some type II PKSs also have an initiation module that
catalyzes the first one or two cycles of polyketide chain growth
(reviewed in Das and Khosla, 2009).
The heterodimeric KS-CLF is central to the activity of type II
PKSs, not only because it catalyzes chain elongation but also
because it controls product length. In well-studied examples
such as the actinorhodin and tetracenomycin PKS, the CLF
subunit has been shown to be necessary and sufficient for
dictating polyketide chain length (McDaniel et al., 1993; Tang
et al., 2003). Because chemical diversity of the resulting natural
products correlates with chain length (Shen et al., 1999), we
sought to investigate the KS-CLF heterodimer from the frederi-
camycin A (1, Figure 1) biosynthetic gene cluster (Wendt-Pien-
kowski et al., 2005).With a C30 backbone this antitumor aromatic
polyketide has the longest known carbon chain length. In earlier
work (Das et al., 2010), we showed that the initiation module of
the fredericamycin (fdm) PKS catalyzes the synthesis of an
ACP-linked C6 intermediate. Therefore, the goal of the current
study was to understand how the fdm KS-CLF catalyzes chain
elongation to its full length. To do so, we functionally reconsti-
tuted it in a heterologous host aswell as in vitro. Using sequence-
and structure-based methods, we designed and expressed a
set of 48 multiple mutants of the CLF gene, and compared the
properties of the resulting KS-CLF heterodimers to those of the
wild-type enzyme. Our findings reveal several fundamentally
novel aspects of how the fdm KS-CLF controls chain length.RESULTS
Reconstitution and Analysis of the fdm PKS
in S. coelicolor CH999
As a first step in our analysis of the fdm KS-CLF, we exploited
the engineered host-vector system Streptomyces coelicolor1031, August 26, 2011 ª2011 Elsevier Ltd All rights reserved 1021
Figure 1. Fredericamycin A, TW94b/c/d, and AD210a
Polyketides cited in this study.
Table 1. 1H- and 13C-NMR Data for AD210a (5)
No.
AD210a (5)
13C 1H
Long-Range
13C-1H HMBC
Correlations
Long-Range
1H-1H COSY
Correlations
1 160.5
2 88.1 5.13 (d, J = 1.7, 1H) C3, C4, C15 H4
3 170.2
4 100.7 5.56 (d, J = 1.7, 1H) C2, C3, C10, C20 H2
5 159.0
6 36.9 3.51 (s, 2H) C4, C7, C8, C11
7 136.9
8 119.1 6.21 (d, J = 1.8, 1H) C6, C10, C11 H10
9 160.5
10 100.1 6.08 (d, J = 1.8, 1H) C9, C12 H8
11 164.7
12 108.3
13 199.7
14 110.1
15 163.5
16 108.4 6.07 (d, J = 3.6, 1H) C15, C18, C21 H18
17 160.2
18 108.3 6.16 (d, J = 3.6, 1H) C8, C16, C17, C20 H16
19 144.7
20 33.1 2.19 (t, J = 6.5, 2H) C12, C19, C21 H21
21 31.4 1.21 (p, J = 5.9, 6.5, 2H) C20, C22, C23 H20, H22
22 30.3 1.14 (m, 2H) C20, C21, C23 H21, H23
23 21.8 1.04 (m, 2H) C21, C22, C24 H22, H24
24 13.9 0.78 (t, J = 5.75, 3H) C21, C22, C23 H23
1H- and 13C-NMR data were recorded in DMSO-d6 (500 MHz for
1H and
125 MHz for 13C). Chemical shifts are reported in d (ppm). Coupling
constants are reported in hertz (Hz). Carbons are labeled according to
their number in polyketide backbone.
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Fredericamycin Ketosynthase-Chain Length FactorCH999/pRM5 (McDaniel et al., 1993). Plasmid pAD201 was con-
structed harboring the KS-CLF (fdmFG) and ACP (fdmH) genes.
We also inserted the fdmW phosphopantetheinyl transferase
gene on this plasmid because previous studies had demon-
strated that, absent this enzyme, the fdm ACP is inactive in the
native host S. griseus (Wendt-Pienkowski et al., 2005) as well
as S. coelicolor CH999 (Das et al., 2010). Plasmid pAD201 was
introduced via transformation into S. coelicolor CH999 along
with a secondary plasmid pBOOST*, which amplifies the copy
number of the cloned PKS genes, thereby enhancing protein
expression as well as product formation (Hu et al., 2003). Two
previously characterized undecaketides (TW94b and TW94c,
Figure 1) and one known dodecaketide (TW94d, Figure 1) were
isolated as the major products from an ethyl acetate:methanol
(90:10) extract of this recombinant strain. TW94b (2), TW94c
(3), and TW94d (4) were produced in a 2:1:2 ratio. Their identities
were verified by 1H- and 13C-NMR in comparison to authentic
standards (Yu et al., 1998). Two conclusions can be drawn
from this finding. First, in the absence of the initiation module,
the minimal fdm PKS catalyzes chain initiation via decarboxyla-
tive priming of a malonyl extender unit. Second, and more
importantly, the minimal fdm PKS intrinsically appears to be a
dodecaketide synthase. (The concomitant biosynthesis of unde-
caketides TW94b and TW94c along with the dodecaketide
TW94d has precedence in a number of spore pigment PKSs,
such as the whiE PKS; Yu et al. [1998].)
To interrogate the influence of the initiation module on the
minimal PKS, the fdmS, fdmC, and fdmO genes were inserted
onto plasmid pAD201, yielding plasmid pAD210. The resulting
transformant, S. coelicolor CH999/pAD210/pBOOST*, synthe-
sized a new product AD210a (5, Figure 1) with an observed
molecular mass of 439 and 441 (in negative and positive ioniza-
tion modes, respectively) by ESI-MS. High-resolution ESI-MS
analysis yielded a molecular formula of C24H24O8Na (calculated
463.1361, observed 463.1369). The structure of AD210a was
solved by 1H- and 13C-NMR spectroscopic analysis as well as
HSQC, HMBC, and COSY NMR experiments (Table 1), and re-
vealed that, even in the presence of the initiation module, the1022 Chemistry & Biology 18, 1021–1031, August 26, 2011 ª2011 Elfdm KS-CLF preferentially synthesizes carbon chain backbones
up to 24 carbon atoms in length.Purification and In Vitro Reconstitution of the fdm
Minimal PKS
The His6-tagged holo-ACP and KS-CLF heterodimer from the
fdm minimal PKS were individually expressed and purified to
homogeneity (Figure 2A, lanes 3 and 6, respectively). (The KS
and the His6-CLF have virtually identical molecular masses,
and cannot be resolved on SDS-PAGE.) Whereas the holo-
ACP was produced in E. coli BAP1, the KS-CLF could only be
functionally expressed in S. coelicolor CH999. The MAT from
S. coelicolor was expressed in E. coli BL21(DE3). These protein
preparations were incubated individually and in selected combi-
nations with [14C]-malonyl-CoA (Figure 2B). By itself only the
MAT could be labeled (lane 2). When incubated with the MAT
and [14C]-malonyl-CoA, the holo-ACP was also labeled (lane
4). Weak labeling of the KS-CLF and the holo-ACPwas observed
in the absence of the MAT (lane 5); the precise reason for this
observation was not investigated. When [14C]-malonyl-CoAsevier Ltd All rights reserved
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Figure 2. Biochemical Characterization of
the Minimal Fredericamycin PKS
(A) SDS-PAGE analysis of purified components of
the fdm minimal PKS. Lane 1 indicates protein
molecular weight standard, lane 2 S. coelicolor
MAT, lane 3 holo-ACP, lane 4 protein molecular
weight standard, lane 5 KS-CLF I134Fmutant, and
lane 6 wild-type KS-CLF. The two subunits have
nearly identical molecular masses (44 and 42 kDa,
respectively) and, therefore, cannot be resolved
via SDS-PAGE.
(B) Activity of the minimal fdm PKS. PKS compo-
nents were individually or collectively incubated
with [14C]-malonyl-CoA and quenched after
30 min: lane 1, ACP; lane 2, MAT; lane 3, KS-CLF;
lane 4, ACP plus MAT; lane 5, ACP plus KS-CLF;
and lane 6, ACP plus KS-CLF plus MAT.
(C) Activity of the fdmPKS harboring the I134FCLF
mutation: lane 1, ACP; lane 2, MAT; lane 3, KS-
CLF; lane 4, ACP plus MAT; and lane 5, ACP plus
KS-CLF plus MAT. The labeled band between the
MAT and ACP in lanes 6 (B) and 5 (C) has not been
characterized but has precedence in the context of
other type II PKSs (Dreier and Khosla, 2000).
(D) Activity of purified fdm minimal PKS: lane 2,
minimal PKS in the presence of [14C]-malonyl-CoA
(quenched at 1 hr); lane 1, control sample pre-
incubated with cerulenin for 20 min; and lane 3,
control sample lacking the KS-CLF.
(E) Activity of the fdm PKS harboring the I134F CLF
mutation: lane 1, minimal PKS in the presence of
[14C]-malonyl-CoA (quenched at 1 hr); and lane 2,
the fdm PKS harboring the I134F CLF mutation in
the presence of [14C]-malonyl-CoA (quenched at
1 hr).
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the ACP were strongly labeled (lane 6), consistent with the
expectation that oligoketides with higher specific radioactivity
than malonyl-CoA are attached to their active sites. Taken
together, these radio-SDS-PAGE results support the establi-
shed model for minimal PKS activity, in which the MAT sup-
plies malonyl units to the ACP, whereas polyketide biosynthesis
involves back-and-forth transfer of the growing chain between
the KS and the ACP.
To verify the ability of the reconstituted fdm minimal PKS to
turn over, a radio-TLC (thin-layer chromatography) assay was
performed (Figure 2D). In lane 2 the minimal PKS is observed
to convert malonyl-CoA into polyketide products of unconfirmed
structure. Notwithstanding repeated attempts on different types
of mass spectrometers, we were unable to verify the identity
of the products synthesized in vitro as TW93b, TW93c, or
TW93d, the expected undeca- or dodecaketide products of
the PKS (Yu et al., 1998). Nonetheless, two observations support
the assumption that the observed radiolabeled products are
polyketides synthesized by the fdmminimal PKS. First, omission
of the KS-CLF resulted in complete loss of activity (Figure 2D,Chemistry & Biology 18, 1021–1031, August 26, 2011 ªlane 3). Second, preincubation of the
KS-CLFwith the irreversible inhibitor, cer-
ulenin, also abolished product formation
(Figure 2D, lane 1). Kinetic measurements
showed that the minimal PKS turned overwith a Vmax of 0.27 mM/min, as judged by the rate of formation of
the polyketide products observed in Figure 2D, lane 2. This
corresponds to a kcat of 0.03 min
1 (referenced to the KS
concentration), a comparable value to the turnover number of
the act minimal PKS (Carreras and Khosla, 1998).
Given our inability to unambiguously identify the released
product(s) of the fdmminimal PKS in vitro, we used electrospray
ionization (ESI) Fourier transform mass spectrometry (FT-MS) to
verify its catalytic activity and to characterize the ACP-bound
intermediates. Recently, a 40-phosphopantetheine (PPant) ejec-
tion assay (Figure 3A) has been developed that allows the
masses of ACP-bound substrates and intermediates to be deter-
mined (Dorrestein and Kelleher, 2006; Meluzzi et al., 2008). The
reaction mixture containing malonyl-CoA, holo-ACP, MAT, and
the KS-CLF was incubated at room temperature for 30 min,
following which the PPant ejection assay was performed. As
seen in Figure 3B (see also MS3 analysis in Figures S1–S7, which
are available online), the predominant PPant ejection peaks
corresponded to a tetraketide, a pentaketide, a cyclized tetra-
ketide, and a cyclized pentaketide. Whereas these data do not
allow us to verify the longest chain length attainable by the fdm2011 Elsevier Ltd All rights reserved 1023
Figure 3. FT-MS Spectra of Acyl-Pantetheine Ejection Ions
(A) Overview of PPant ejection assay. Tandem-MS results in characteristic ejection ions bearing polyketide intermediates, which are subjected to further
tandem-MS analysis to yield diagnostic fragments. In-source fragmentation of the ACP simultaneously yields multiple pantetheine ejection ions bearing different
polyketide intermediates. Results from the following reactions are presented:
(B) Wild-type fdm PKS.
(C) fdm PKS harboring the I134F mutation in the CLF. The peak labeled (*) is a prominent, unrelated ion.
Additional information for each intermediate identified by PPant ejection assay is provided in Figures S1–S7.
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lytically active.
Design, Synthesis, and Characterization
of an fdm CLF Mutant Library
A major challenge for structure-function analysis or engineering
of the fdmCLF (or any other CLF) is the lack of a high-throughput
assay that is adequately sensitive to polyketide product charac-
teristics. To mitigate this limitation, we used a synthetic gene
approach to construct a modest library of 48 fdm CLF mutants.
Mutants were designed via a combination of sequence and
structure-based approaches, as well as available literature1024 Chemistry & Biology 18, 1021–1031, August 26, 2011 ª2011 Eldata. Specifically, the amino acid sequences of 31 CLF homo-
logs were aligned using CLUSTAL W (Thompson et al., 1994)
(Figure S8). Two types of scores were assigned to each position
in the alignment (Minshull et al., 2005). The first score, termed
‘‘alternate conservation,’’ identifies relatively conserved residues
whose identity correlates with chain length specificity of the
PKS. Namely, PKSs producing shorter polyketide backbones
share a conserved residue at this position, whereas those that
synthesize longer chains share an alternative conserved residue.
A higher alternate conservation score suggests that an amino
acid change at this position has greater potential to influence
chain length. The second score, termed ‘‘entropy,’’ reflects thesevier Ltd All rights reserved
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sequence alignment, and is calculated with reference to the
Dayhoff substitution matrix. A more conserved residue has a
higher entropy score. A total of 20 residues with the highest
alternate conservation scores was targeted in the first set of 24
variants, whereas 15 substitutions selected on the basis of
entropy scores were combined with 5 substitutions identified
from previous analyses of the actinorhodin CLF (Keatinge-Clay
et al., 2004; Tang et al., 2003) to design the second set of 24 vari-
ants. Because each variant harbored multiple mutations relative
to the wild-type fdm CLF, each substitution was programmed to
occur at the same frequency (i.e., five or six times). Moreover,
individual mutations in a given variant were randomly combined.
Thus, the variants were designed to maximize the number of
different pairs of substitutions in the full set of variants. The
complete set of variants is defined in Table 2.
The product profiles of the 48 variants are summarized in
Table 3. A total of 12 variants (527, 532, 533, 540, 543, 544,
547, 549, 550, 557, 561, and 564) did not produce TW94b,
TW94c, or TW94d. The inactivity of variant 533, which harbors
D18G, F77L, Y121W, G129S, and V326A mutations, could not
be exclusively ascribed to a single modification because each
mutation was also found in other biosynthetically competent
variants. Radio-SDS-PAGE analysis of the corresponding puri-
fied KS-CLF confirmed its inability to be labeled in the presence
of MAT, holo-ACP, and [14C]-malonyl-CoA (data not shown).
Further analysis of variant 533 was not undertaken because its
phenotype was likely due to the combined effect of multiple
residues.
Variants 527, 532, 540, 543, and 544, whose designs were
based on the alternate conservation score, all harbored the
I134F mutation, whereas variants 547, 549, 550, 557, 561, and
564, whose designs were based on the entropy score, shared
the G113T mutation. Because both sets of variants exhibited a
null phenotype in vivo, the KS-CLF heterodimer from a represen-
tative variant of each set was purified. The G113T-harboring
mutant was not labeled under any circumstance (data not
shown); however, the I134F-harboring mutant showed inter-
esting characteristics. To unambiguously assign the observed
properties to the I134 residue, we first constructed and ex-
pressed a mutant CLF harboring a single change (I134F). The
resulting transformant S. coelicolor CH999/pAD201-I134F/
pBOOST* produced no detectable polyketide metabolite.
In Vitro Analysis of the I134F Mutant of the fdm CLF
Using a similar protocol to the wild-type enzyme purification
procedure, the KS-CLF heterodimer harboring the I134F muta-
tion in the CLF was purified to homogeneity (Figure 2A, lane 5).
As predicted from the in vivo phenotype of this mutant, radio-
TLC analysis failed to show evidence of polyketide production
in the presence of MAT, holo-ACP, and [14C]-malonyl-CoA
(Figure 2E). However, an unexpected labeling pattern was
observed by radio-SDS-PAGE analysis (Figure 2C). When
[14C]-malonyl-CoA was incubated with MAT, holo-ACP, and
the mutant KS-CLF, both the ACP and the KS were strongly
labeled (Figure 2C, lane 5). The intensity of protein labeling was
suggestive of the possibility that polyketide intermediates were
covalently attached to the holo-ACP. To test this hypothesis,
a reaction mixture containing malonyl-CoA, the holo-ACP, theChemistry & Biology 18, 1021–MAT, and the mutant KS-CLF was incubated at room tempera-
ture for 30 min and analyzed via FT-MS. The same ACP-bound
intermediates observed in the wild-type reaction (i.e., a tetra-
ketide, a pentaketide, a cyclized tetraketide, and a cyclized
pentaketide) were also observed in the case of the I134F mutant
(Figure 3C), implying that although thismutant was unable to turn
over, it could initiate and (at least partially) elongate polyketide
chains.
DISCUSSION
The fdm PKS is a bimodular synthase that is believed to synthe-
size the longest known (C30) polyketide backbone produced by
a type II PKS (Das et al., 2010; Wendt-Pienkowski et al., 2005).
Its initiation module synthesizes a C6 primer unit and transfers
it to the elongationmodule (Das et al., 2010), which then presum-
ably incorporates 12malonyl extender units (Figure 4). In all other
type II PKSs studied thus far, chain length specificity is exclu-
sively programmed in the KS-CLF heterodimer (reviewed in
Das and Khosla, 2009). For example, investigations into the ac-
tinorhodin and benastatin PKSs have shown that the number of
decarboxylative condensation cycles catalyzed by their KS-CLF
heterodimers depends on the size of the primer unit (Nicholson
et al., 2003; Tang et al., 2004; Xu et al., 2007, 2009). Our findings
reported here suggest that the fdm KS-CLF is an exception to
this rule in that it only synthesizes C22–C24 backbones instead
of the expected C30 backbone (Figure 4). Therefore, it is likely
that an as yet unidentified auxiliary protein encoded by the fdm
gene cluster modifies the inherent chain length specificity of
the fdm KS-CLF, in effect enlarging its substrate-binding pocket.
Further investigations are warranted to elucidate the mechanism
bywhich this most remarkable synthase controls product length.
Besides being of fundamental interest, the ability of the fdm
PKS to synthesize exceptionally long poly-b-ketoacyl chains
also offers an attractive starting point for the engineering of
biosynthetically useful enzymes. Here, we have used sequence
and structure-based concepts together with machine learning
algorithms and high-throughput gene synthesis to identify two
important residues, I134 and G113, in the fdm CLF. The I134F
mutant is particularly noteworthy because, to our knowledge, it
is the first example of a CLF mutant that can initiate and elon-
gate, but not terminate, polyketide chain growth. Earlier efforts
to modify the substrate-binding pocket of the act and tcm CLF
proteins resulted in mutants that retained the ability to turn
over but had altered backbone length specificity (Tang et al.,
2003). Alternatively, mutants such as G113T and variant 533 of
the fdm CLF (reported here) are completely inactive. In contrast
the partial activity of the I134F mutant suggests that chain termi-
nation by the KS-CLF is not simply a default event that occurs
when further growth of the polyketide backbone is no longer
possible. A homology model of the fdm KS-CLF, based upon
the X-ray crystal structure of the act KS-CLF (Keatinge-Clay
et al., 2004), is shown in Figure 5. According to this model,
I134 is located at the intersubunit interface. We speculate that
the I134F mutation creates a steric block in the substrate-
binding channel straddling this interface. However, in contrast
to earlier CLF mutants with alterations in the substrate-binding
channel (Tang et al., 2003), the product of the I134F mutant
is not released. Therefore, chain termination must require1031, August 26, 2011 ª2011 Elsevier Ltd All rights reserved 1025
Table 2. List of the Variants with Their Corresponding Mutations
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Chemistry & Biology 18, 1021–repositioning of a full-length chain to promote its ejection from
the elaborate substrate-binding pocket. Further structural and
mechanistic analysis of this fdm PKS mutant will not only shed
light on the mechanism of chain length control but could also
provide entirely new insights into the mechanism of chain termi-
nation by type II PKSs.SIGNIFICANCE
Type II polyketidesynthases (PKSs)catalyze thebiosynthesis
of highly reactive poly-b-ketoacyl chains of defined length.
Understanding and engineering polyketide chain length offer
the opportunity to rationally manipulate the structures of
many interesting antibiotics. We have harnessed a variety
of approaches to study the ketosynthase-chain length factor
(KS-CLF) heterodimer from the fredericamycin PKS. Al-
though fredericamycin is derived from a C30 backbone, we
show that its KS-CLF synthesizes products in the C22–C24
range. Thus, this heterodimeric enzyme appears unique in
that its chain length specificity is considerably shorter than
the backbone length of the final product. We have also iden-
tified a prototypical CLF mutant that permits chain initiation
and elongation, but not termination. Further characterization
of this mutant should yield fundamentally new insights into
the mechanisms by which carbon chains of defined length
are synthesized and released.EXPERIMENTAL PROCEDURES
Materials
Radiolabeled coenzyme A (CoA) substrates were from American Radiolabeled
Chemicals (St. Louis). All other biochemicals were from Sigma-Aldrich
(St. Louis). Deuterated solvents for NMR experiments were from Cambridge
Isotope Laboratories (Andover, MA, USA); all other solvents were from Fisher
Scientific (Pittsburgh) at highest available grade. HiTrap Q anion-exchange
column was from GE Healthcare (Madison, WI, USA). Precast SDS-PAGE
gels were from Invitrogen (Carlsbad, CA, USA). PCR was performed using
PfuTurbo Hotstart polymerase (Stratagene, La Jolla, CA, USA), and amplimers
were sequence verified prior to use. Plasmids used for cloning included
pLitmus28i, pUC18 (New England BioLabs, Ipswich, MA, USA), and pET28b
(EMD Bioscience, Madison, WI, USA). All cloning steps were performed in
E. coli XL1-Blue (Stratagene). Unmethylated DNA was obtained by passaging
plasmids through the methylase-deficient strain E. coli ET12567. Protoplast
preparation and PEG-assisted transformation were performed as described
byHopwoodandcolleagues (Kieser et al., 2000).S.coelicolorCH999/pBOOST*
(Hu et al., 2003) and E. coli strains BL21(DE3) or BAP1 (Pfeifer et al., 2001) were
used for polyketide isolation and protein expression, respectively.
Cloning
The fdm PKS genes were synthesized to introduce suitable restriction sites
and ribosomal-binding sites. The 50 and 30 sequences for fdmC, fdmF,
fdmG, fdmH, fdmO, fdmS, and fdmW were engineered as follows:
fdmC: TCTAGAGGAGGAGCCCATATGCTCACGCCCGGCCGG-GGCGG
GATCGCCCTGTGACTAGTggtaccgagctcGAATTC;
fdmF: TCTAGAttaattaaGGAGGACCCATATGACCGCACGTGCGGTG-CCG
AGGAGGATCGCATGAACTAGTaagctt;
fdmG: TCTAGAGGAGGACCCATATGACCGGGCCCGTCATC-GTCCTCA
GATCCGTCTGAACTAGTaagctt;
fdmH: TCTAGAGGAGGAGCGCATATGAGCACCATCAGCTTC-CTGTGT
GAGGGGGTCTGACTAGTggtaccgagctcGAATTC;
fdmO: TCTAGABGGAGGAGCCCATATGGAACTTCGACTGGTA-GTCGAC
GGGGGTGTCTGACTAGTaagctt;1031, August 26, 2011 ª2011 Elsevier Ltd All rights reserved 1027
Table 3. In Vivo Product Profile of fdm CLF Variants
Variant Set 1 Variant Set 2
Identity Product Profile Identity Product Profile
521 TW94b/TW94c/TW94d 545 TW94b/TW94c/TW94d
522 TW94b/TW94c/TW94d 546 TW94b/TW94c/TW94d
523 TW94b/TW94c/TW94d 547 Null
524 TW94b/TW94c/TW94d 548 TW94b/TW94c/TW94d
525 TW94b/TW94c/TW94d 549 Null
526 TW94b/TW94c/TW94d 550 Null
527 Null 551 TW94b/TW94c/TW94d
528 TW94b/TW94c/TW94d 552 TW94b/TW94c/TW94d
529 TW94b/TW94c/TW94d 553 TW94b/TW94c/TW94d
530 TW94b/TW94c/TW94d 554 TW94b/TW94c/TW94d
531 TW94b/TW94c/TW94d 555 TW94b/TW94c/TW94d
532 Null 556 TW94b/TW94c/TW94d
533 Null 557 Null
534 TW94b/TW94c/TW94d 558 TW94b/TW94c/TW94d
535 TW94b/TW94c/TW94d 559 TW94b/TW94c/TW94d
536 TW94b/TW94c/TW94d 560 TW94b/TW94c/TW94d
537 TW94b/TW94c/TW94d 561 Null
538 TW94b/TW94c/TW94d 562 TW94b/TW94c/TW94d
539 TW94b/TW94c/TW94d 563 TW94b/TW94c/TW94d
540 Null 564 Null
541 TW94b/TW94c/TW94d 565 TW94b/TW94c/TW94d
542 TW94b/TW94c/TW94d 566 TW94b/TW94c/TW94d
543 Null 567 TW94b/TW94c/TW94d
544 Null 568 TW94b/TW94c/TW94d
Set 1 includes variants whose design was based on high ‘‘alternate
conservation’’ scores, whereas set 2 includes variants designed based
on ‘‘entropy’’ scores. For details see text.
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CGGCTCCCCTGACTAGTaagctt; and
fdmW: TCTAGAGGAGGAGCCCATATGCAACCTGACGACGAG-GTCGTC
GGTGCGGCCTGACTAGTggtaccgagctcGAATTC.
The fdmG gene was amplified to introduce a His6-tag with the following
primers:
fdmG_FP: AATTCTAGAGGAGGACCCATATGCATCATCATCATCATCAT
ACCGGGCCCGTCCATCACCGGGGTGGGCG; and
fdmG_RP: AGCGAATTCGGGGACTAGTTCAGACGGCTCTGAGGACCA.
The underlined sequence encodes the His6-tag. Restriction sites are indicated
in italicsor in lowercase, and ribosomal-bindingsitesare inbold. Thegenes fdmF,
fdmH, and fdmWwere cloned into pLitmus28i vector by XbaI/HindIII digestion to
introduce an EcoRI site at the 30 end. They were then assembled as synthetic
operons in pUC18 prior to transfer into a pRM5-derived shuttle vector (McDaniel
et al., 1993). The first gene in each operon was inserted between the XbaI and
EcoRI sites in pUC18; subsequent genes were inserted downstream following
SpeI/EcoRIdigestionof thevectorandXbaI/EcoRIdigestionof the insert.Plasmid
pAD201was constructedby excising the complete operon byPacI/EcoRI diges-
tion, which was inserted between the PacI/EcoRI sites of shuttle vector pRM5.
The fdmS, fdmC, and fdmO genes were inserted onto plasmid pAD201 by
a similar method described above, yielding plasmid pAD210.
Protein Expression and Purification
S. coelicolor CH999/pAD201/pBOOST* was the source of the His6-tagged
fdm KS-CLF. Spore suspensions of each strain were used to inoculate1028 Chemistry & Biology 18, 1021–1031, August 26, 2011 ª2011 El4 3 1 liters minimal medium (6.25% [w/v] PEG 8000, 25 mM TES [pH 7.2],
0.5% [w/v] Casamino acids, 1% [w/v] glucose, 15 mM (NH4)2SO4, 5 mM
MgSO4, 1.25 mM NaH2PO4, 1.25 mM K2HPO4, 926 nM FeCl3, 377 nM
ZnCl2, 99 nMMnCl2, 73 nMCuCl2, 33 nMNa2B4O7, 10 nM (NH4)6Mo7O24) con-
taining 50 mg/l thiostrepton and 100 mg/l apramycin. Mycelia from the
stationary phase cultures (about 2 days) were collected by centrifugation,
and resuspended in 140 ml disruption buffer (200 mM NaH2PO4 [pH 7.1],
200 mM NaCl, 30% [v/v] glycerol, 2.5 mM EDTA, 2 mM DTT, 1.5 mM Benza-
midine, 4.3 mM leupeptin, 2.9 mM pepstatin). Cells were disrupted by sonica-
tion, and the cell debris was removed by centrifugation (17,000 rpm for
30 min). DNA was precipitated by adding 0.2% polyethyleneimine (PEI), fol-
lowed by centrifugation (17,000 rpm for 30 min). The KS-CLF protein was
precipitated between 30% and 50% (NH4)2SO4. Precipitated proteins were
redissolved in 100mMNaH2PO4 (pH 7.4) and incubatedwith 2ml Ni-NTA resin
(QIAGEN) for 2 hr at 4C. The slurry was poured into a capped column, and
washed with 20 ml of the first wash buffer (50 mM sodium phosphate,
300 mM NaCl, 20 mM imidazole [pH 8.0]), followed by 4 ml of the second
wash buffer (50 mM sodium phosphate, 300 mM NaCl, 50 mM imidazole [pH
8.0]). The KS-CLF heterodimer was eluted with elution buffer (50 mM sodium
phosphate, 100 mM NaCl, 250 mM imidazole [pH 8.0]). Fractions containing
the KS-CLF were pooled and buffer exchanged into 45 ml of buffer A (50 mM
TrisdHCl [pH 8.0] 1 mM TCEP, and 10% glycerol) and loaded onto a HiTrap Q
column pre-equilibrated with buffer A. The following gradient was applied to
this column: 0% buffer B (buffer A with 500 mM NaCl) from 0 to 20 min; 10%
buffer B from 20 to 25 min; 80% buffer B from 25 to 85 min; and 100% buffer
B from 85 to 100 min. The target protein eluted at 48% buffer B. The eluent
was concentrated, buffer exchanged into a storage buffer (100 mM NaH2PO4
[pH 7.4], 2 mM TCEP, 2 mM EDTA, and 15% glycerol), flash frozen with liquid
nitrogen, and stored at 80C. The typical yield of purified fdm KS-CLF was
1 mg/l.
The fdm holo-ACP was expressed in an engineered E. coli strain BAP1
(Pfeifer et al., 2001) to obtain its 40-phosphopantetheinylated form. Protein
expression was induced at an OD600 of 0.6 with 200 mM IPTG, and allowed
to proceed at 18C for 18 hr. Cells were harvested and lysed by sonication.
The protein was initially purified on Ni-NTA resin, followed by anion exchange
chromatography on a HiTrap Q column (from 0 to 500mMNaCl in 60min). The
proteins eluted at 200 mM NaCl. Purified protein was buffer exchanged into
100 mM sodium phosphate, 15% glycerol (pH 7.2), and stored at 80C.
The relative ratio of the holo and apo forms of the ACP was quantified by
LC-MS, and was found to be 50% in the holo form. The typical yield of puri-
fied ACP was 12 mg/l.
The S. coelicolor MAT gene was expressed in E. coli BL21(DE3), and the
MAT protein was purified as described previously (Carreras and Khosla,
1998). The typical yield of purified MAT was 15mg/l. All protein concentrations
were determined by the Bradford method with the Bio-Rad protein kit.
Detection of Covalently Bound Protein Intermediates
by Radio-SDS-PAGE
To investigate the enzymatic activity of PKS components in vitro, selected pro-
tein combinations were incubated with radiolabeled substrates and analyzed
via radio-SDS-PAGE. For example a PKS reaction mixture (12 ml) contained
200 mM [14C]-malonyl-CoA (55 Ci/mol), 10 mM of the fdm KS-CLF, 25 mM
holo-ACP, and 1 mM MAT in a buffer containing 100 mM sodium phosphate
(pH 7.3), 2 mM EDTA, and 2 mM TCEP. Following incubation at room temper-
ature for 30 min, the reaction was quenched with 6 ml of nonreducing sample
buffer (0.1% bromophenol blue, 1% SDS, 40% glycerol), and loaded directly
onto a 4%–12% SDS gel. Following staining, dried gels were subjected to
autoradiography.
Radio-TLC Analysis of PKS Activity In Vitro
This assay detects polyketides synthesized by the fdm minimal PKS from
radiolabeled malonyl-CoA. Assays were performed at 30C in 30 ml of reaction
buffer, as described above. Reaction mixtures contained 50 mM holo-ACP,
10 mM KS-CLF, 0.1 mM MAT, and 1 mM [14C]-malonyl-CoA (55 Ci/mol). The
reaction was initiated by adding [14C]-malonyl-CoA, and quenched at 2, 4, 6,
10, and 20 min by adding 200 ml ethyl acetate. Each quenched mixture was
vortexed and extracted with 200 ml ethyl acetate twice. The combined organic
phases were evaporated to dryness and redissolved in 15 ml ethyl acetate. Thesevier Ltd All rights reserved
AB
C
Figure 4. Proposed Biosynthesis of the Polyketides Cited in This Study
(A) Proposed biosynthesis of TW94b, TW94c, and TW94d by the fdm minimal PKS and the act KR in S. coelicolor CH999/pAD201/pBOOST*. The act KR is
a ketoreductase from the actinorhodin biosynthetic pathway.
(B) Proposed biosynthesis of AD210a by the bimodular fdm PKS in S. coelicolor CH999/pAD210/pBOOST*. The DH (dehydratase) and ER (enoyl reductase)
involved in the initiation module are derived from the housekeeping fatty acid synthase in S. coelicolor.
(C) Proposed biosynthesis of fredericamycin A in S. griseus.
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acetate and 1% acetic acid, and quantified with a phosphoimager. Cerulenin
was used at a final concentration of 1 mM.
Production, Isolation, and Characterization of Polyketide Products
For small-scale cultivations, Streptomyces strains were grown on R5 agar
plates containing 50 mg/l thiostrepton and 100 mg/l of apramycin at 30CChemistry & Biology 18, 1021–for 7 days. For HPLC analysis the pigmented agar medium from 10 to 12 plates
was mashed and extracted with methanol/ethyl acetate (10:90). The solvent
was evaporated in vacuo, and the residue was dissolved in methanol. The
mixture was analyzed by reverse-phase HPLC outfitted with a UV-Vis detector
at 280 and 410 nm, using the Apollo C18 column (250 3 4.6 mm). A linear
gradient from 30% acetonitrile (MeCN) in water (0.1% TFA) to 55% MeCN in
water (0.1% TFA) was used over 40 min with a flow rate of 1 ml/min.1031, August 26, 2011 ª2011 Elsevier Ltd All rights reserved 1029
Figure 5. Homology Model of the fdm KS-CLF and Crystal Structure
of the act KS-CLF
Homology model of the fdm KS-CLF (A) along with the structurally charac-
terized act KS-CLF (B). The KS and CLF subunits are shown as green and blue
ribbons, respectively. The active site of the KS (C169) and residue 134 of the
fdm CLF (F133 is an equivalent residue in the act CLF) are shown in balls and
sticks. Polyketide chain growth is initiated via decarboxylation of malonyl-
ACP, followed by transfer of the resultant acetyl group onto C169 residue of
the KS. The growing polyketide chain is transferred back and forth between
and Cys169 residue of the KS and the pantetheinyl thiol of the ACP until it
reaches full length. At this point the chain fully occupies the substrate-binding
channel (shown in red) and is subsequently released.
Chemistry & Biology
Fredericamycin Ketosynthase-Chain Length FactorFor preparative scale studies the aforementioned fermentation and extrac-
tion procedures were scaled up to 3–4 liters of R5 agar medium. The solvent
was removed in vacuo. The crude extract was flashed through a silica gel
column using 1% acetic acid in ethyl acetate. The eluent was dried, redis-
solved in 3–4 ml methanol, and injected onto the preparative reverse-phase
HPLC column (250 3 22 mm, C18 column, Vydac). Gradients used included
10%–40% MeCN in water (0.1% TFA) over 80 min or 20%–60% MeCN in
water (0.1% TFA) over 100 min, with a flow rate of 5 ml/min. Purified fractions
were dried in vacuo or by lyophilization. In cases where further purification was
warranted, the relevant HPLC fraction was redissolved in 0.5–1ml acetone and
applied to a preparative TLC plate, which was developed in a solvent system
consisting of ethyl acetate and hexane with or without 1% acetic acid. 1H- and
13C-NMR spectra of purified polyketide products were recorded on Varian
Inova 500. The 1H-NMR spectra were referenced at 2.49 ppm in DMSO-d61030 Chemistry & Biology 18, 1021–1031, August 26, 2011 ª2011 Elor 3.31 ppm in CD3OD. The
13C-NMR spectra were referenced at 39.5 ppm
in DMSO-d6.
Synthesis of Genes Encoding CLF Variants
High-throughput gene synthesis was carried out to synthesize these variants
(Villalobos et al., 2006).
Detection of Covalently Bound Intermediates Using ESI FT-MS
A reaction mixture (50 ml) contained 1 mMmalonyl-CoA, 6.9 mMKS-CLF hetero-
dimer, 34.7mMholo-ACP, and0.7mMMAT inabuffer containing100mMsodium
phosphate (pH 7.3), 2 mMEDTA, and 2mM TCEP. Following incubation at room
temperature for 30 min, the reaction mixtures were purified using the Phenom-
enex C4 column (150 3 4.6 mm). A linear gradient from 10% acetonitrile
(MeCN) in water (0.1% TFA) to 90% MeCN in water (0.1% TFA) was used over
30 min with a flow rate of 1 ml/min. The eluent was collected as 1 ml fractions,
lyophilized to dryness, and redissolved in anESI solvent containing 49.5%water,
49.5% methanol, and 1% formic acid for FT-MS analysis. ESI FT-MS analysis
was performed on a Thermo Electron LTQ-FT-ICR hybrid mass spectrometer.
The HPLC fraction containing the fdmACPwas redissolved in the ESI solvent
and directly introduced into themass spectrometer with an Advion BioSciences
NanoMate 100Biversa nanospray source. The instrument was operated in posi-
tive ion mode, using an electrospray voltage between 1.35 and 1.45 kV and gas
pressure of 0.35 psig. Samples were subjected to in-source fragmentation by
adjusting the skimmer voltage to 75V. In-source fragmentation allowed for ejec-
tion of the PPant arm from theACP, alongwith anyacyl-intermediate bound to it.
The identities of these pantetheine-bound intermediates were determined by
intact exact mass analysis followed by MS/MS (MS3) fragmentation. In order
to achieve sufficient ion intensity for MS3 identification, pantetheine ejection
ionswere trappedusingan isolationwidthof 4m/zcenteredon the ionof interest.
MS3 fragmentation employed the following settings: normalized collision energy
of 30%; an activation Q of 0.200–0.230; and an activation time of 50–100 ms
depending on the intensity of the particular pantetheine ejection ion being iden-
tified. All spectra were recorded by FT-ICR-MS with a resolution of 100,000.
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